1 Min Read
Nov 1 (Reuters) - Edge Therapeutics Inc
* Edge Therapeutics reports third quarter 2017 financial results
* Edge Therapeutics Inc - qtrly loss per share $0.37 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.